Published in Langmuir on December 02, 2011
Classification of Magnetic Nanoparticle Systems--Synthesis, Standardization and Analysis Methods in the NanoMag Project. Int J Mol Sci (2015) 0.90
Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater (2015) 0.86
Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect. J Mater Chem B Mater Biol Med (2014) 0.77
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev (2008) 8.23
Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev (2006) 4.69
Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals (2008) 1.49
Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol (2006) 1.48
Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol (2008) 1.41
The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology (2009) 1.38
Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab (2012) 1.21
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine (2007) 1.21
Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging. Biomaterials (2005) 1.10
Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol Pharm (2009) 1.09
Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. J Phys Chem B (2009) 1.03
A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles. J Am Chem Soc (2006) 1.02
Role of thermodynamic and kinetic parameters in gadolinium chelate stability. J Magn Reson Imaging (2009) 1.01
Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology (2008) 0.98
Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. Angew Chem Int Ed Engl (2012) 0.97
Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol (2003) 0.96
Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update. Radiol Clin North Am (2009) 0.94
Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study. Invest Radiol (2011) 0.94
In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T. Magn Reson Med (2012) 0.93
Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Arterioscler Thromb Vasc Biol (2012) 0.93
Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research. Curr Pharm Des (2013) 0.92
Clinical, biological, and skin histopathologic effects of ionic macrocyclic and nonionic linear gadolinium chelates in a rat model of nephrogenic systemic fibrosis. Invest Radiol (2011) 0.90
Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. Int J Pharm (2006) 0.90
Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. J Med Chem (2009) 0.89
A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med (2010) 0.89
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Crit Rev Toxicol (2014) 0.88
19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles. Angiogenesis (2012) 0.87
The iron oxides strike back: from biomedical applications to energy storage devices and photoelectrochemical water splitting. Adv Mater (2011) 0.85
Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure. Toxicol Sci (2012) 0.85
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Mol Pharm (2012) 0.84
Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles. Magn Reson Imaging (2007) 0.84
High sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen. NMR Biomed (2011) 0.84
Thermal-induced phase transitions in self-assembled mesostructured films studied by small-angle X-ray scattering. J Synchrotron Radiat (2005) 0.83
Bioinorganic transformations of liver iron deposits observed by tissue magnetic characterisation in a rat model. J Inorg Biochem (2006) 0.83
In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. Contrast Media Mol Imaging (2010) 0.82
The role of phosphate on Omniscan(®) dechelation: an in vitro relaxivity study at pH 7. Biometals (2011) 0.82
Synthesis of pyrimidines and triazines in ice: implications for the prebiotic chemistry of nucleobases. Chemistry (2009) 0.82
Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates. Eur J Nucl Med Mol Imaging (2010) 0.82
Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting. Magn Reson Med (2008) 0.81
Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery. J Control Release (2008) 0.81
Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles. Nanomedicine (Lond) (2010) 0.80
Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla. Invest Radiol (2008) 0.79
Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents. ACS Nano (2010) 0.78
Structural characterization of ultrasmall superparamagnetic iron oxide (USPIO) particles in aqueous suspension by energy dispersive X-ray diffraction (EDXD). J Am Chem Soc (2006) 0.78
Thermal wet decomposition of Prussian Blue: implications for prebiotic chemistry. Chem Biodivers (2009) 0.77
Thermodynamic and structural properties of Eu3+ complexes of a new 12-membered tetraaza macrocycle containing pyridine and N-glutaryl groups as pendant arms: characterization of three complexing successive phases. Dalton Trans (2007) 0.77
Transmission electron microscopy of lipid vesicles for drug delivery: comparison between positive and negative staining. Microsc Microanal (2010) 0.77
Re: chemical structure and stability of gadolinium chelates. Radiographics (2009) 0.75
Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents. Invest Radiol (2014) 0.75
Comments on a possible transition to solid-phase homochirality. Chemistry (2007) 0.75
Synthesis of polycyclic aromatic hydrocarbons and acetylene polymers in ice: a prebiotic scenario. Chem Biodivers (2008) 0.75
Femtosecond nonlinear absorption of gold nanoshells at surface plasmon resonance. Phys Chem Chem Phys (2010) 0.75
Metastability in supersaturated solution and transition towards chirality in the crystallization of NaClO3. Angew Chem Int Ed Engl (2011) 0.75
Comparison of the high relaxivity Gd chelates P1152 and Gd-BOPTA for contrast-enhanced MR angiography in rabbits at 1.5 Tesla and 3.0 Tesla. J Magn Reson Imaging (2010) 0.75
Core-shell iron-iron oxide nanoparticles synthesized by laser-induced pyrolysis. Small (2006) 0.75
Homochirality as a consequence of thermodynamic equilibrium? Chemistry (2006) 0.75
Achiral-to-chiral transition in benzil solidification: analogies with racemic conglomerates systems showing deracemization. Chirality (2013) 0.75
Valence band circular dichroism in non-magnetic Ag/Ru(0001) at normal emission. J Phys Condens Matter (2011) 0.75
Arterial concentration profiles of two blood pool agents and Gd-DOTA after intravenous injection in rabbits. Acad Radiol (2002) 0.75
Fluorine insertion into the Ruddlesden-Popper phase La2BaFe2O7: the structure and magnetic properties of La2BaFe2O5F4. Dalton Trans (2014) 0.75
Local-field enhancement and plasmon tuning in bimetallic nanoplanets. Opt Express (2007) 0.75
The Viedma deracemization of racemic conglomerate mixtures as a paradigm of spontaneous mirror symmetry breaking in aggregation and polymerization. Chemphyschem (2013) 0.75
Transmetallation as an effective strategy for the preparation of bimetallic CoPd and CuPd nanoparticles. Nanoscale (2014) 0.75
Relationship between physico-chemical properties of magnetic fluids and their heating capacity. Int J Hyperthermia (2013) 0.75
Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility. Biomed Tech (Berl) (2015) 0.75
Iridium/silicon multilayers for extreme ultraviolet applications in the 20-35 nm wavelength range. Opt Lett (2011) 0.75
Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging. Contrast Media Mol Imaging (2014) 0.75
New synthesis of a high molecular weight ligand derived from dota; thermodynamic stability of the MRI contrast agent formed with gadolinium. Contrast Media Mol Imaging (2008) 0.75